These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 3519004

  • 21. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM, Doelle GC, Alexander AN, Uderman HD, Rabin D.
    J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
    [Abstract] [Full Text] [Related]

  • 22. Mechanism of action and pure antiandrogenic properties of flutamide.
    Labrie F.
    Cancer; 1993 Dec 15; 72(12 Suppl):3816-27. PubMed ID: 8252497
    [Abstract] [Full Text] [Related]

  • 23. Hormonal therapy for patients with advanced adenocarcinoma of the prostate: is there a role for discontinuing treatment after prolonged androgen suppression?
    Pedraza R, Kwart AM.
    Urology; 2003 Apr 15; 61(4):770-3. PubMed ID: 12670563
    [Abstract] [Full Text] [Related]

  • 24. Continued desensitization of the pituitary gland in young bulls after treatment with the luteinizing hormone-releasing hormone agonist deslorelin.
    Bergfeld EG, D'Occhio MJ, Kinder JE.
    Biol Reprod; 1996 Apr 15; 54(4):769-75. PubMed ID: 8924495
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action.
    Furr BJ, Tucker H.
    Urology; 1996 Jan 15; 47(1A Suppl):13-25; discussion 29-32. PubMed ID: 8560673
    [Abstract] [Full Text] [Related]

  • 30. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S, Heber D, Steiner BS, Handelsman DJ, Swerdloff RS.
    J Clin Endocrinol Metab; 1985 May 15; 60(5):998-1003. PubMed ID: 3920237
    [Abstract] [Full Text] [Related]

  • 31. Elevation of serum testosterone during chronic LHRH agonist treatment in the bull.
    Melson BE, Brown JL, Schoenemann HM, Tarnavsky GK, Reeves JJ.
    J Anim Sci; 1986 Jan 15; 62(1):199-207. PubMed ID: 3007418
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Combined long-term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat.
    Lefebvre FA, Séguin C, Bélanger A, Caron S, Sairam MR, Raynaud JP, Labrie F.
    Prostate; 1982 Jan 15; 3(6):569-78. PubMed ID: 6296803
    [Abstract] [Full Text] [Related]

  • 34. Long-term endocrine effects of administration of either a non-steroidal antiandrogen or a luteinizing hormone-releasing hormone agonist in men with prostate cancer.
    Decensi A, Torrisi R, Fontana V, Marroni P, Padovani P, Guarneri D, Minuto F, Boccardo F.
    Acta Endocrinol (Copenh); 1993 Oct 15; 129(4):315-21. PubMed ID: 8237249
    [Abstract] [Full Text] [Related]

  • 35. Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration.
    Pavlou SN, Dahl KD, Wakefield G, Rivier J, Vale W, Hsueh AJ, Lindner J.
    J Clin Endocrinol Metab; 1988 May 15; 66(5):1005-9. PubMed ID: 2834409
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Inhibition of pituitary-testicular function with [D-Trp6] luteinizing hormone-releasing hormone in rhesus monkeys.
    Sundaram K, Connell KG, Bardin CW, Samojlik E, Schally AV.
    Endocrinology; 1982 Apr 15; 110(4):1308-14. PubMed ID: 6460610
    [Abstract] [Full Text] [Related]

  • 38. Morphological studies of the canine pituitary luteinizing hormone (LH) cells after long-term treatment with the LH-releasing hormone (LHRH) agonist [D-Trp6]LHRH ethylamide.
    Dubé D, Pelletier G, Labrie F.
    Endocrinology; 1987 Feb 15; 120(2):589-94. PubMed ID: 3542506
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.